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Iron (Fe) is an essential element for all eukaryotic organisms because it functions as a cofactor in a wide range of biochemical
processes. Cells have developed sophisticated mechanisms to tightly control Fe utilization in response to alterations in cellular
demands and bioavailability. In response to Fe deficiency, the yeast Saccharomyces cerevisiae activates transcription of the CTH1
and CTH2 genes, which encode proteins that bind to AU-rich elements (AREs) within the 3= untranslated regions (3=UTRs) of
manymRNAs, leading to metabolic reprogramming of Fe-dependent pathways and decreased Fe storage. The precise mecha-
nisms underlying Cth1 and Cth2 function and regulation are incompletely understood.We report here that the Cth1 and Cth2
proteins specifically bind in vivo to AREs located at the 3=UTRs of their own transcripts in an auto- and cross-regulated mecha-
nism that limits their expression. By mutagenesis of the AREs within the CTH2 transcript, we demonstrate that a Cth2 negative-
feedback loop is required for the efficient decline in Cth2 protein levels observed upon a rapid rise in Fe availability. Impor-
tantly, Cth2 autoregulation is critical for the appropriate recovery of Fe-dependent processes and resumption of growth in
response to a change from Fe deficiency to Fe supplementation.
Iron (Fe) is an essential micronutrient for all eukaryotic organ-isms because it participates as a heme, Fe-S cluster, or oxodiiron
cofactor in multiple processes, including oxygen sensing and
transport, the tricarboxylic acid (TCA) cycle, mitochondrial res-
piration, DNA replication and repair, lipid metabolism, and pro-
tein translation (1–4). In humans, Fe imbalances underlie many
diseases, including hereditary hemochromatosis, Friedreich’s
ataxia, and aceruloplasminemia (5–8). Despite its abundance, Fe
bioavailability is highly restricted due to its low solubility at phys-
iological pH. Indeed, human Fe deficiency is the most widespread
nutritional disorder in the world, affecting more than 2 billion
people and leading to anemia, mainly in women and children, that
is reversed by dietary Fe supplementation (9).
Eukaryotic organisms have developed sophisticated mecha-
nisms to optimize Fe acquisition, distribution, utilization, storage,
and mobilization. Multiple regulatory factors are interconnected
to coordinate the cellular responses to Fe imbalances due to alter-
ations in Fe bioavailability or changes in metabolic Fe needs. In
mammals, the Fe-regulatory proteins IRP1 and IRP2 tightly con-
trol cellular Fe metabolism (6, 7, 10). Under Fe-deficient condi-
tions, IRP proteins bind to specific stem-loop RNA structures de-
noted Fe-responsive elements (IREs) within the 5= untranslated
region (5=UTR) in multiple mRNAs, including the Fe storage pro-
tein ferritin, the Fe efflux pump ferroportin, and enzymes, such as
mitochondrial aconitase and erythroid aminolevulinic acid syn-
thase, thereby inhibiting their translation. Furthermore, IRP
binding to IREs within the 3=UTR of the transferrin receptor tran-
script promotes its stabilization, leading to an increase in its trans-
lation. This coordinated regulation allows Fe-deficient cells to in-
crease uptake of Fe-loaded transferrin and decrease Fe storage in
ferritin. When Fe availability resumes, IRP1 acquires an Fe-S clus-
ter that converts it into cytoplasmic aconitase, and FBXL5 protein
interacts with IRP2, promoting its ubiquitination and degrada-
tion (11–13).
In the yeast Saccharomyces cerevisiae, Fe regulation is con-
trolled by both transcriptional and posttranscriptional mecha-
nisms. When environmental Fe levels are high, the high-affinity Fe
acquisition systems are not expressed, and Fe enters the cell
through low-affinity transporters. Under these conditions, the
Yap5 transcription factor activates the expression of CCC1, en-
coding a vacuolar Fe transporter that mediates Fe detoxification
(7), although it has been demonstrated that Yap5 only partially
regulates the expression of CCC1 (14). In response to Fe scarcity,
two Fe-responsive transcription factors, Aft1 and Aft2, induce the
transcription of a set of genes denoted the Fe regulon, which en-
codes proteins involved in high-affinity Fe uptake at the plasma
membrane, Fe mobilization from vacuolar stores, and metabolic
reprogramming of Fe-consuming pathways (15–17). Within this
Fe regulon are genes encoding two mRNA-binding proteins, Cth1
and Cth2, characterized by the presence of two tandem zinc fin-
gers (TZFs) of the CX8CX5CX3H type, which are conserved in the
mammalian family of tristetraprolin (TTP) mRNA-destabilizing
proteins (18–20). While Cth1 is transiently expressed in the early
stages of Fe deficiency, Cth2 expression increases during the prog-
ress of Fe limitation, reaching its maximum levels when Fe defi-
ciency persists (19, 20). Cth1 and Cth2 bind through their TZFs to
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specific AU-rich elements (AREs) located in the 3=UTRs of many
mRNAs, recruiting the Dhh1 helicase to promote the cytoplasmic
5=-to-3= turnover of target transcripts (19–21). Cth2 also modu-
lates the 3=-end processing of ARE-containing mRNAs by pro-
moting the degradation of extended transcripts (22, 23). In re-
sponse to Fe limitation, the ARE-containing 3=UTR of Cth1/Cth2
target mRNAs is sufficient to promote the downregulation of
genes that are not regulated by Fe, such asGCN4, in a manner that
is fully dependent on AREs and Cth1/Cth2 TZFs (19). Cth1 and
Cth2 target transcripts are only partially redundant, since Cth1
promotes the degradation of mRNAs encoding proteins that func-
tion in highly Fe-consuming processes, such as mitochondrial res-
piration, whereas Cth2 exhibits a broader set of targets that in-
cludes the TCA cycle and respiration, lipid metabolism, heme
synthesis, amino acid biosynthesis, and the Ccc1 vacuolar Fe im-
porter (19, 20). In addition to promoting the downregulation of a
wide variety of Fe-dependent processes, Cth1 and Cth2 also func-
tion in the activation of essential Fe-dependent enzymes, such as
ribonucleotide reductase, which functions in the synthesis of the
deoxyribonucleotides necessary for DNA synthesis and repair, by
degrading an mRNA encoding the Wtm1 nuclear anchoring pro-
tein, facilitating the assembly of an active cytosolic enzyme (24).
Cells lackingCTH2 or expressing a nonfunctionalCTH2TZF mu-
tant allele display growth defects under low-Fe conditions that are
exacerbated upon deletion of CTH1 (19). Therefore, Cth1 and
Cth2 act in concert as molecular rheostats that allow metabolic
adaptation to various degrees of Fe limitation. While Cth1 may be
involved in adaptation to a transient or modest Fe deficiency, Cth2
likely promotes a generalized metabolic shift to optimize Fe utili-
zation during more severe or prolonged Fe deprivation.
Although Fe-dependent changes in gene expression are crucial
for Fe homeostasis and shifts in Fe availability, the mechanisms
underlying Cth1/2 function and regulation are incompletely un-
derstood. In this study, we demonstrate that CTH1 and CTH2
mRNAs contain functional AREs within their 3=UTRs that func-
tion in auto- and cross-regulation for the decay of their respective
mRNAs. Our results strongly suggest that this tight control of
Cth1 and Cth2 levels is important for the replacement of Cth1
by Cth2 during prolonged Fe limitation and for the rapid decrease
in Cth2 levels that is required for the adaptation to Fe supplemen-
tation following Fe deficiency.
MATERIALS AND METHODS
Plasmids. The Escherichia coli DH5 strain was used for the propagation
and isolation of plasmids. The CTH1 and CTH2 3=UTRs were cloned into
the pRS416-GCN4-No-3=UTR plasmid by using an EcoRI restriction site
introduced after the GCN4 termination codon (19) to generate pRS416-
GCN4-(CTH2-3=UTR) and pRS416-GCN4-(CTH1-3=UTR) constructs.
The GCN4-CTH1-3=UTR fragment was cloned into the pRS415 vector to
obtain pRS415-GCN4-(CTH1-3=UTR). Sequences from the CTH1 and
CTH2 3=UTRs (see Fig. 3B) were cloned into SmaI-digested pIIIA/MS2-1
vector (25) to obtain pIIIA/MS2-CTH1 and pIIIA/MS2-CTH2. The
pRS416-FLAG2-CTH2-C190R, pRS416-FLAG2-CTH2-C223R, pRS416-
CTH2p-CTH1-C225R, pRS416-GCN4-(CTH2-3=UTR-AREmt), pRS416-
FLAG2-CTH2-AREmt, and pIIIA/MS2-CTH2-AREmt plasmids were
generated by using the overlap extension method and the corresponding
nonmutagenized plasmids as templates (19, 20). All plasmids containing
CTH1 or CTH2 coding sequences, including those with an amino-termi-
nal tag, are expressed under the control of their own promoter unless
otherwise indicated. Other plasmids used in this work have been de-
scribed previously (19, 20, 24, 25). All PCR amplifications were performed
with the Phusion polymerase (Finnzymes), and cloned inserts were se-
quenced.
Yeast strains and growth conditions. The S. cerevisiae strains used in
this study were wild-type BY4741 (MATa his31 leu20 met150
ura30) and the isogenic mutant cth1 (cth1::KanMX6), cth2 (cth2::
HisMX6), gcn4 (gcn4::KanMX6), cth1 cth2 (cth1::KanMX4 cth2::
HisMX6), and cth1 cth2 gcn4 (cth1::KanMX4 cth2::HisMX6 gcn4::
hphB) strains. Yeast cells were grown in synthetic complete medium (SC)
or SC lacking specific requirements. The Fe2-specific chelator batho-
phenanthroline disulfonic acid disodium (BPS) (Sigma) was used to im-
pose Fe deficiency, and ferrous ammonium sulfate (FAS) (Sigma) was
added to create Fe-replete conditions.
To quantify cell growth in liquid media (see Fig. 7), a preculture was
grown to exponential phase (A600, 0.5 to 0.6) and diluted 200-fold be-
fore reinoculation. Cells were grown in SC lacking uracil (SCura) or
SCura with 100 M BPS (Fe deficient [Fe]) or reinoculated from
SCura precultures with 100 M BPS into SCura containing 100 M
FAS (Fe sufficient [Fe]) or SCura without glucose but with 2% glyc-
erol. The optical density was determined over time at 25°C by using a
Bioscreen analyzer C (Thermo Labsystems) with a broadband filter (420
to 580 nm) at 30-min intervals over 48 h. Each culture was grown in
triplicate, and the average data are shown. The data were corrected for the
analyzer by correcting loss of linearity as described previously (26).
Protein analyses. Total-protein extracts were obtained by glass bead
lysis of whole yeast cells in buffer A (50 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 15 mM EDTA, 0.1% Triton X-100, 2 mM dithiothreitol, 1 mM
phenylmethylsulfonyl fluoride) using a Mini Beadbeater (Biospec Prod-
ucts). Protein concentrations were determined by the Coomassie dye-
binding assay (Bio-Rad). An equal amount of protein was separated by
SDS-PAGE on 12% TGX gels (Bio-Rad) and analyzed by immunoblotting
using the indicated antibodies. Flag antibody was purchased from Sigma
(F1804-200UG; 080M6035), and Sdh2 antibody was donated by B.
Lemire. Primary antibodies were incubated for at least 2 h at room tem-
perature. After washing the membranes, they were incubated with the
corresponding secondary antibody (enhanced chemiluminescence [ECL]
anti-rabbit or anti-mouse IgG; GE Healthcare), and immunoblots were
visualized with SuperSignal chemiluminescent substrate (ThermoScien-
tific).
RNA analyses. Total yeast RNA was isolated with a modified hot-
phenol method (27). For RNA blots, approximately 30 g of RNA per
lane was separated in formaldehyde-agarose gels and blotted onto nylon
membranes (Hybond N; Amersham Biosciences). PCR-amplified frag-
ments were gel purified and radiolabeled with [-32P]dCTP to be used as
probes in hybridizations in PSE buffer (300 mM NaH2PO4-Na2HPO4, pH
7.2, 7% SDS, 1 mM EDTA) at 65°C. Actin (ACT1) was used as a loading
control. Signal intensities were quantified using a Fujifilm BAS-1500
phosphorimager.
For quantitative real-time PCR (qRT-PCR), genomic DNA was elim-
inated using Turbo DNA-free (Ambion), and cDNA synthesis was per-
formed according to the recommendations for the SuperScript III first-
strand synthesis system (Invitrogen). qRT-PCR was performed using iQ
SYBR green Supermix on a Bio-Rad iQ5 real-time PCR detection system.
The amplification conditions consisted of a starting step of denaturation
at 95°C for 3 min, followed by 39 cycles of 95°C for 10 min, 55°C for 10
min, and 72°C for 30 min. After 10 min at 95°C to terminate the reaction,
the PCR plate was maintained at 4°C until its analysis. The results were
normalized to ACT1 and analyzed by the 2CT method as previously
described (28). Statistical significance was determined using Student’s t
test.
Succinate dehydrogenase assays. Mitochondrion-enriched fractions
were prepared from exponential yeast cultures at an optical density at 600
nm (OD600) of 0.8 as described previously (29). Succinate dehydrogenase
(SDH) assays were performed with p-iodonitrotetrazolium violet as an
artificial electron acceptor for the SDH complex. Protein extracts were
incubated in 300 l of succinate buffer (10 mM succinic acid in 50 mM
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phosphate buffer, pH 7.4) with 100 l of p-iodonitrotetrazolium violet
solution (2.5 mg of p-iodonitrotetrazolium violet in 50 mM phosphate
buffer, pH 7.4). Reactions were terminated with 1 ml of stop solution (10
g of trichloroacetic acid in 100 ml of ethyl acetate-ethanol [1:1 {vol/vol}]),
and the absorbance of the supernatant was measured at 490 nm. Error
bars represent the standard deviations of duplicate determinations of four
independent assays.
Miscellaneous methods. Yeast three-hybrid and -galactosidase as-
says were performed as previously described (25, 27).
RESULTS
AutoregulationofCth2 expression throughanegative-feedback
loop. In response to Fe deficiency, yeast cells increase the expres-
sion of Cth2 mRNA and protein, which facilitates metabolic ad-
aptation by targeted mRNA turnover (19, 21, 24, 30). Mutagenesis
of specific cysteine residues (C190R and C213R) within Cth2 TZF
domains abrogates the Cth2 capacity for binding and degradation
of ARE-containing mRNAs (19, 21). We observed that CTH2 al-
leles mutagenized within the TZF coding region (C190R and
C213R alleles) display increased steady-state transcript and pro-
tein levels under low-Fe conditions that are achieved by addition
of the Fe2-specific chelator BPS compared to wild-type CTH2
(Fig. 1A and B). Interestingly, the CTH2 mRNA 3=UTR sequence
contains a putative ARE beginning 46 nucleotides (nt) after the
CTH2 translation termination codon. Previous studies have
shown that mutagenesis of this ARE in a reporter transcript con-
taining the CTH2 3=UTR leads to a significant increase in tran-
script stability and steady-state levels (22). Therefore, we decided
to explore the possibility that Cth2 regulates its mRNA abundance
by binding to and degrading its own mRNA. To test this hypoth-
esis, we first ascertained whether the CTH2 3=UTR was able to
promote the low-Fe-dependent degradation of the transcript en-
coded by a reporter gene that is not regulated in response to Fe
deficiency (19). For this purpose, the CTH2 3=UTR was fused to
the GCN4 coding sequence, and the steady-state levels of GCN4-
(CTH2-3=UTR) chimeric mRNA were measured under Fe and
Fe conditions (Fig. 1C). Whereas wild-type GCN4 mRNA levels
are not significantly altered by Fe availability, GCN4-(CTH2-
3=UTR) mRNA is downregulated in response to Fe limitation (Fig.
1C). Importantly, mutagenesis of the 5=-UUAUUUAUUAUU
U-3= ARE in CTH2-3=UTR to 5=-UUCUUUCUUCUUU-3= com-
pletely abrogates the Fe-dependent downregulation of GCN4-
(CTH2-3=UTR) mRNA (Fig. 1C). Moreover, the decrease in
GCN4-(CTH2-3=UTR) transcript in response to Fe deficiency is
dependent on a functional Cth2 protein. As shown in Fig. 1D, the
Fe deprivation-dependent decrease in GCN4-(CTH2-3=UTR)
steady-state mRNA levels is abolished in cells that lack CTH2 or
express the nonfunctional CTH2-C190R allele. Taken together,
these results demonstrate that the ARE sequence found in the
CTH2 3=UTR is necessary and sufficient to induce the Cth2 and Fe
starvation-dependent downregulation of GCN4 mRNA and
strongly suggest that Cth2 utilizes a negative-feedback loop that
limits its own expression.
Cth2protein regulates the expression levels ofCTH1mRNA.
Our previous studies demonstrated that the TZF-containing pro-
tein Cth1 cooperates with Cth2 in the metabolic adaptation to Fe
deficiency via targeted mRNA degradation (19, 20). In fact, the
CTH1 promoter region contains two Fe-responsive elements that
are essential for the Aft1/Aft2-dependent activation ofCTH1 tran-
scription upon Fe limitation (20). Despite this, only modest ele-
vation in the steady-state CTH1 mRNA levels is observed when
cells are grown under low-Fe conditions, and only a transient
increase in Cth1 protein levels is detected (19, 20). Intriguingly, we
have observed that CTH1 steady-state mRNA levels increase in
cells that do not express CTH2 or that express a nonfunctional
Cth2 protein mutated at Cys190 or Cys213 (Fig. 2A). Further-
more, while transient expression of a FLAG epitope-tagged Cth1
FIG 1 Cth2 autoregulates expression through a negative-feedback loop involving binding to its own ARE and promoting mRNA decay. (A) A cth1 cth2
double mutant was transformed with pRS416-CTH2 (CTH2), pRS416 (vector), pRS416-CTH2-C190R (CTH2-C190R), or pRS416-CTH2-C213R (CTH2-
C213R) plasmid. Cells were grown for 8 to 9 h in SCura containing 100M FAS (Fe) or 100M BPS (Fe), and RNA was extracted and analyzed for CTH2
expression by RNA blotting. Relative quantitation ofCTH2 andACT1,CTH2-C190R andACT1, andCTH2-C213R/ACT1mRNAs underFe conditions was 1.0,
1.9, and 1.7, respectively. (B) A cth1 cth2 double mutant was transformed with pRS416-FLAG2-CTH2 (CTH2), pRS416 (vector), pRS416-FLAG2-CTH2-
C190R (CTH2-C190R), or pRS416-FLAG2-CTH2-C213R (CTH2-C213R) plasmid. The cells were grown as described for panel A. Protein was extracted and
analyzed by immunoblotting using anti-FLAG antibody. (C) A gcn4 strain was transformed with pRS416-GCN4 (GCN4), pRS416-GCN4-(CTH2-3=UTR)
(GCN4-CTH2), or pRS416-GCN4-(CTH2-3=UTR-AREmt) (GCN4-CTH2-AREmt). Cells were grown and analyzed for GCN4 mRNA expression levels as
described for panel A. (D) A cth1 cth2 gcn4 triple mutant transformed with pRS415-GCN4-(CTH2-3=UTR) was cotransformed with pRS416-CTH2 (Cth2),
pRS416 (vector), or pRS416-CTH2-C190R (C190R). Cells were grown in SCuraleu and analyzed as for panel C. Actin (ACT1) was used as a loading control
in all RNA-blotting assays, and Pgk1 was used as a loading control in all immunoblot assays.
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protein was previously observed in wild-type cells during Fe defi-
ciency (20), FLAG-Cth1 protein levels are induced by Fe defi-
ciency and sustained in cells that do not express Cth2 (Fig. 2B).
Given that the CTH1 3= region contains three putative AREs lo-
cated 53, 80, and 159 nt after the CTH1 termination codon, we
hypothesized that CTH1 mRNA could be a target for Cth2-medi-
ated degradation under Fe deficiency conditions. To test whether
the CTH1-3=UTR confers Cth2-dependent Fe-regulated mRNA
decay, theCTH1 3= region was fused to theGCN4 coding sequence
and the steady-state levels of GCN4-(CTH1-3=UTR) mRNA were
assayed under Fe and Fe conditions. As observed for the
CTH2 3=UTR, the CTH1 3=UTR promotes the downregulation of
GCN4 mRNA upon Fe deficiency in a manner that is fully depen-
dent on the presence of a functional Cth2 protein (Fig. 2C). Taken
together, these results demonstrate that the CTH1 3=UTR is nec-
essary and sufficient to induce the Cth2 and Fe starvation-depen-
dent downregulation of GCN4 mRNA and strongly suggest that
Cth2 promotes the downregulation of CTH1 expression under
Fe-deficient conditions.
Cth1 and Cth2 bind both CTH1 and CTH2mRNAs. The re-
sults shown here indicate that both mRNA binding by Cth2 pro-
tein and cis-acting AREs are essential for the downregulation of
bothCTH1 andCTH2mRNAs. Additional experimental evidence
supports the notion that Cth1 also downregulates the CTH1 and
CTH2 mRNAs. First, it has been previously reported that the dis-
ruption of the CTH1 gene results in the accumulation of CTH2
mRNA (31). By using a CTH2 promoter-CTH1 fusion gene con-
struct and a CTH2-C190R allele that eliminates Cth2-dependent
regulation, we observed that CTH2 mRNA levels are lower in cells
that express a functional CTH1 allele than in cth1 mutants or
cells expressing the nonfunctional CTH1-C225R allele, strongly
suggesting that the Cth1 protein downregulates CTH2 mRNA
(data not shown). Moreover, using a cth1 cth2 gcn4 strain
that expresses either a wild-type Cth1 protein or one in which
Cys225 was mutated to arginine from the CTH2 promoter, and a
GCN4-(CTH1-3=UTR) fusion gene, we observed that a functional
Cth1 protein specifically promotes the downregulation of aGCN4
mRNA containing theCTH1 3=UTR, suggesting that Cth1 protein
also autoregulates its own mRNA levels via its 3=UTR (data not
shown).
Taken together, these results suggest that both the Cth1 and
Cth2 proteins auto- and cross-regulate the expression of their
mRNAs and predict that both proteins should specifically bind to
the AREs contained within the 3=UTRs of both the CTH1 and
CTH2 mRNAs. To test this possibility, the in vivo interaction be-
tween the Cth1 or Cth2 protein and the CTH1 or CTH2 mRNA-
derived sequences was evaluated by using the yeast three-hybrid
assay, a genetic surrogate for detecting protein-RNA interactions
(25) (Fig. 3A). For this purpose, sequences from the 3=UTRs of
CTH1 and CTH2 mRNAs containing potential AREs, and the
same CTH2 3= region with a mutagenized ARE (Fig. 3B), were
fused to DNA encoding bacteriophage MS2 RNA. Moreover, the
coding sequences of CTH1, CTH1-C225R, CTH2, or CTH2-
C190R were fused in frame to the Gal4 transactivation domain.
Plasmids were cotransformed into the L40coat yeast strain, which
expresses a protein fusion between the LexA DNA-binding do-
main and the MS2 coat protein, and growth was assayed in me-
dium lacking histidine. The IRP/IRE system of mRNA-binding
protein and mRNA target sequence was used as a positive control
for growth in the absence of histidine, which is indicative of pro-
tein-RNA interactions. As shown by growth in medium without
histidine, Cth1 and Cth2, but not Cth1-C225R and Cth2-C190R
proteins, interact with sequences derived from CTH1 and CTH2
mRNAs but not with CTH2 mRNA with a mutagenized ARE (Fig.
3C). Given that the L40coat strain expresses the LacZ gene under
the control of the LexA DNA-binding domain, we quantitatively
confirmed the interaction between the Cth1/Cth2 proteins and
the CTH1 and CTH2 mRNAs by -galactosidase assays (Fig. 3D).
Taken together, these results indicate that the Cth1 and Cth2 pro-
teins specifically bind in vivo to both CTH1 and CTH2 mRNAs,
and this binding promotes their downregulation in a tight auto-
and cross-regulated mechanism that interconnects the expression
of both genes.
CTH2mRNA downregulation is important for rapid extinc-
tionofCth2expressionpromotedbya switch fromFedeficiency
to Fe supplementation. We have shown here that under Fe-defi-
cient conditionsCTH2-C190R andCTH2-C213RmRNA and pro-
tein levels are higher than those displayed by wild-typeCTH2 (Fig.
1), likely due to the lack of Cth2-mediated autodegradation. Based
FIG 2 Cth2 downregulates CTH1 mRNA levels in response to Fe deficiency.
(A) A cth2 mutant was transformed with pRS416-CTH2 (CTH2), pRS416
(vector), pRS416-CTH2-C190R (C190R), or pRS416-CTH2-C213R (C213R).
Cells were grown and analyzed forCTH1mRNA expression levels as described
for Fig. 1A. Relative quantitation ofCTH1 andACT1mRNA levels is shown in
reference to CTH2-expressing cells underFe conditions. (B) A cth1 cth2
double mutant was cotransformed with pRS415-FLAG2-CTH1 plus pRS416-
CTH2 (FLAG-CTH1  CTH2) or pRS415-FLAG2-CTH1 plus pRS416
(FLAG-CTH1 vector). BPS (100 M) was added to exponential-phase cells
growing in SCuraleu, and aliquots were analyzed for Flag2-Cth1 protein
expression as described for Fig. 1B. (C) A gcn4 mutant strain was trans-
formed with pRS416-GCN4 (GCN4) or pRS416-GCN4-(CTH1-3=UTR)
(GCN4-CTH1) plasmid, and a cth1 cth2 gcn4 triple mutant transformed
with pRS415-GCN4-(CTH1-3=UTR) (GCN4-CTH1 3=UTR) and cotrans-
formed with pRS416-CTH2 (CTH2), pRS416 (vector), or pRS416-CTH2-
C190R (CTH2-C190R). gcn4 and cth1 cth2 gcn4 transformants were
grown in SCura and SCuraleu, respectively, containing 100 M FAS
(Fe) or 100M BPS (Fe) and analyzed for GCN4 mRNA expression levels
as described for Fig. 1A. Actin (ACT1) was used as a loading control in all
RNA-blotting assays, and Pgk1 was used as a loading control in all immuno-
blot assays.
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on this observation, we hypothesized that this autoregulation
strategy would be important for the downregulation of CTH2 ex-
pression that should occur upon Fe addition to an Fe-deficient
medium. To test this hypothesis, yeast cells expressing either
FLAG-CTH2 or the FLAG-CTH2-AREmt allele were grown under
Fe sufficiency conditions (SC-ura), and Fe bioavailability was de-
creased by addition of 100M BPS to chelate extracellular Fe and
activateCTH2 expression. After 6 h of growth under Fe limitation,
100 M FAS was added to restore Fe-replete conditions, and the
cells were grown for a further 2 h. As suggested by our previous
results withCTH2-TZFmutants (Fig. 1), the analysis ofCTH2 and
CTH2-AREmt mRNA levels by qRT-PCR indicated that the ARE
functions in the control of CTH2 mRNA levels in response to Fe
deficiency (Fig. 4A). After Fe readdition, both CTH2 and CTH2-
AREmt mRNA levels rapidly decreased. Importantly, CTH2-
AREmt mRNA abundance was higher than that observed for
CTH2 transcript during early times after Fe addition (Fig. 4A),
strongly suggesting that the integrity of the CTH2 ARE is essential
for the rapid downregulation of its expression that occurs upon Fe
repletion.
To test whether theCTH2ARE is important for the downregu-
lation of steady-state Cth2 protein levels, we determined Flag-
Cth2 protein levels in these cells. Consistent with the increase in
Cth2-TZF mutant protein levels that we observed during Fe lim-
itation (Fig. 1), mutagenesis of the CTH2 ARE leads to a signifi-
cant increase in Cth2 protein abundance compared to cells ex-
pressing wild-type CTH2 (Fig. 4B). Furthermore, Cth2 protein
expressed from the wild-type gene was not detectable after 15 min
of Fe readdition, whereas in cells that express the CTH2-AREmt
allele, Cth2 protein was still detected 30 min after Fe addition (Fig.
4B). Taken together, these results demonstrate that the CTH2
ARE is required to limit Cth2 expression levels under low-Fe con-
ditions and to allow more efficient downregulation of both CTH2
mRNA and protein when cells are switched from Fe-deficient to
Fe-supplemented growth conditions.
Cth2 downregulation upon Fe supplementation is impor-
tant for the reemergence of Fe-dependent processes. Cth2 pro-
tein is responsible for the downregulation of approximately 90
ARE-containing mRNAs encoding proteins that participate in Fe-
dependent processes, including respiration and heme synthesis,
and proteins that function in Fe compartmentalization, such as
the Ccc1 vacuolar Fe importer (19, 21, 32). Consequently, we
ascertained whether the sustained Cth2 protein levels observed
after the readdition of Fe in cells expressing the CTH2-AREmt
allele impacted the expression of Cth2 target genes at both the
mRNA and protein levels. The mRNA levels of Cth2 targets, in-
FIG 3 Cth1 and Cth2 proteins specifically interact with CTH1 and CTH2 mRNAs. (A) Schematic representation of the yeast three-hybrid Cth1/Cth2 and
CTH1-CTH2 3=UTR assay. (B) 3=UTR sequences used in the yeast three-hybrid assay. The MS2 RNA was fused to CTH1, CTH2, and CTH2-AREmt. G residues
(in italics) were replaced by U residues to minimize premature termination of the RNA polymerase III transcription unit in yeast. Underlined sequences indicate
putative AREs. (C) L40coat cells were cotransformed with (9) pIIIA/MS2-1 vector alone or containing the 3=UTR fromCTH1,CTH2, orCTH2-AREmtor the IRE
as a positive control, and (38) pACT2 vector alone or fused to Cth2, Cth2-C190R, Cth1, Cth1-C225R, and the Fe-responsive element binding protein 1 (IRP) as
a positive control. Cells were grown on SCuraleu (His) and SCuraleuhis (His) with increasing concentrations of 3-aminotriazol (3AT). (D)
L40coat cells cotransformed with (i) pACT2 vector fused to Cth2, Cth2-C190R, Cth1, or Cth1-C225R and (ii) pIIIA/MS2-1 vector alone or fused to the 3=UTR
from CTH1 or CTH2 were grown on SCleuura and assayed for -galactosidase activity. The error bars indicate standard deviations.
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cluding succinate dehydrogenase subunit 2 (SDH2) and ferroche-
latase (HEM15), were determined by qRT-PCR under the same
conditions used to determine CTH2 mRNA levels in Fig. 4A,
which include Fe-sufficient conditions, Fe-deficient conditions,
and Fe-deficient conditions followed by Fe supplementation. We
observed that in the CTH2-AREmt yeast strain, both mRNAs were
efficiently downregulated in response to Fe deficiency (Fig. 5A and
B). Furthermore, transcript levels for both Cth2 targets progres-
sively increased after Fe addition to Fe-deficient cells (Fig. 5A and
B). Importantly, the elevation of Cth2 target mRNA levels upon Fe
supply is defective in cells that express CTH2-AREmt (Fig. 5A and
B), suggesting that the increased levels of Cth2 protein in these
cells (Fig. 4B) delays the recovery of Cth2 target mRNA levels due
to sustained degradation. To further assess whether this decrease
in Cth2 target transcript abundance correlates with protein levels,
Sdh2 protein abundance was measured by immunoblotting.
Whereas no significant differences were observed for Fe-sufficient
conditions (Fig. 5C), CTH2-AREmt cells exhibited a delay in the
recovery of Sdh2 protein levels upon Fe supplementation com-
pared to cells expressing the wild-type CTH2 allele (Fig. 5D),
closely inversely correlating with the abundance of FLAG-Cth2
protein levels (Fig. 4B). We ascertained whether these defects in
mRNA and protein recovery observed in cells expressing the
CTH2-AREmt allele upon Fe readdition had an effect on the en-
zymatic activity of Cth2-regulated targets. Succinate dehydroge-
nase activity from yeast cells expressing either theCTH2 orCTH2-
AREmt allele was measured under conditions of Fe sufficiency or
Fe deficiency and 4 h after supplementation with exogenous Fe.
Upon Fe recovery, cells expressing the CTH2-AREmt allele exhib-
ited a nearly 50% decrease in succinate dehydrogenase activity
compared to cells expressing wild-type CTH2 (Fig. 6). Taken to-
gether, these results strongly suggest that the ARE-dependent
downregulation of CTH2 mRNA and protein levels that occurs
upon an increase in Fe availability is important for the rapid re-
covery of Fe-dependent processes that are targets of Cth2 protein
under Fe-deficient conditions.
Cth2 negative-feedback regulation is important for growth
during alterations in Fe bioavailability.To ascertain whether the
FIG 4 The CTH2 mRNA ARE regulates CTH2 expression levels. (A) A cth1
cth2 double-mutant strain was transformed with pRS416-FLAG2-CTH2 or
pRS416-FLAG2-CTH2-AREmt. Cells were grown in SCura (SC), and then
100 M BPS was added for 6 h (Fe). After Fe deficiency, 100 M FAS was
added for 2 h (Fe). mRNAs were extracted from the SC and Fe and at
different time points after Fe addition, reverse transcribed, and quantified by
qRT-PCR using specific primers for CTH2 mRNA detection. A representative
experiment is shown. Actin expression was used to normalize mRNA levels.
(B) A cth1 cth2 double-mutant strain was transformed with pRS416-
FLAG2-CTH2 or pRS416-FLAG2-CTH2-AREmt. Cells were grown as de-
scribed for panel A, and aliquots were collected at the indicated times and
analyzed by immunoblotting using anti-FLAG antibody. Pgk1 was used as a
loading control. Molecular masses in kDa are shown on the left. Cells from the
same aliquots were used for both mRNA and protein determinations.
FIG 5 Dysregulation of Cth2 targets in cells with a CTH2 allele defective in autoregulation. (A and B) A cth1 cth2 double-mutant strain transformed with
pRS416-FLAG2-CTH2 or pRS416-FLAG2-CTH2-AREmt plasmid was grown for Fe sufficiency (SC), deficiency (Fe), or deficiency followed by Fe supplementation
(Fe) as described for Fig. 4A. mRNAs were extracted and analyzed by qRT-PCR using specific primers to amplify SDH2 (A) and HEM15 (B). A representative
experiment is shown. Actin expression was used to normalize mRNA levels. (C and D) A cth1 cth2double-mutant strain transformed with pRS416-FLAG2-CTH2 or
pRS416-FLAG2-CTH2-AREmt plasmid was grown as described for Fig. 4A. Samples were analyzed by immunoblotting using polyclonal antibodies against Sdh2 and
Pgk1. Molecular masses in kDa are shown on the left. Different sections from the same immunoblot are shown in panel D.
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defects in Cth2 target regulation observed in cells lacking Cth2
autodegradation impact cell physiology, the growth of cells ex-
pressing the CTH2 or CTH2-AREmt allele under distinct condi-
tions of Fe availability was evaluated, using cth2 mutants and
cells expressing the CTH2-C190R nonfunctional protein as con-
trols for these assays. No growth difference was observed among
the four strains grown in SC (Fig. 7A). Cells expressing wild-type
CTH2 exhibit lower growth rates under Fe deficiency than under
Fe-sufficient conditions (Fig. 7A and B). As previously reported,
yeast cells lackingCTH2 or expressing theCTH2-C190R nonfunc-
tional allele display a significant growth defect under low-Fe con-
ditions compared to cells expressing wild-type CTH2 (Fig. 7B)
(19). Interestingly, yeast cells expressing the CTH2-AREmt allele
also show a growth defect under low-Fe conditions, although it is
not as pronounced as the defect observed for cth2 and CTH2-
C190R cells (Fig. 7B). Similar results are obtained when growth is
assayed in solid medium (data not shown). The growth defect of
CTH2-AREmt cells under low Fe suggests that an excessive accu-
mulation of Cth2 protein is deleterious for cell growth. Consistent
with this observation, previous studies suggested that Cth2 over-
expression can be toxic to S. cerevisiae (21, 31), which may actually
reflect an inability to cope with Fe limitation.
To determine whether CTH2 autoregulation is important for
cell growth when cellular Fe availability rapidly changes, cells were
grown under Fe-deficient conditions (100 M BPS) and then Fe
supplemented by adding 100 M FAS. Cells lacking a functional
CTH2 (cth2 or CTH2-C190R) exhibited a significant delay in
resuming growth compared to wild-type cells (Fig. 7C), suggest-
ing that the optimization of Fe utilization by Cth2 during Fe scar-
city is also important for growth recovery when Fe availability
increases. Importantly, CTH2-AREmt-expressing cells display a
more severe delay in growth recovery when transferred from Fe-
deficient to Fe-sufficient conditions (Fig. 7C), consistent with the
delay in upregulation of Fe-dependent processes shown in Fig. 5
FIG 6 Recovery of succinate dehydrogenase activity is compromised after Fe
supplementation in CTH2-AREmt cells. Mitochondrial SDH activity was
measured in a cth1 cth2 double-mutant strain transformed with pRS416-
CTH2 or pRS416-CTH2-AREmt plasmid. Cells were grown as described for
Fig. 4. Mitochondrion-enriched extracts for SDH analyses were obtained by
differential centrifugation. The analyses were performed with four biological
replicates, and each sample was analyzed in duplicate. The error bars represent
the standard deviations. The asterisk indicates statistically significant differ-
ences by analysis of variance (ANOVA) between yeast cells expressingCTH2or
CTH2-AREmt after Fe readdition (P 0.0005).
FIG 7 Cth2 overaccumulation is a growth disadvantage under conditions of fluctuating Fe availability. A cth1 cth2 double mutant was transformed with
pRS416-CTH2 (CTH2), pRS416 (cth2), pRS416-CTH2-AREmt (AREmt), or pRS416-CTH2-C190R (C190R). For SC growth, cells were maintained in SCura.
For Fe, Fe, and 2% glycerol assays, cells were first grown in SCura containing 100 M BPS to induce Fe deficiency and CTH2 expression and then
transferred to SCura containing either 100M BPS (Fe) or 100M FAS (Fe) or to SCura but with 2% glycerol replacing glucose as the sole carbon source.
Growth curves were obtained by measuring the absorbance at 660 nm every 30 min for 48 h by using a Bioscreen growth analyzer. A representative experiment
of three independent biological replicates with similar results is shown.
Martínez-Pastor et al.
2184 mcb.asm.org Molecular and Cellular Biology
and 6. As respiration is an Fe-dependent process and some Cth2
targets encode proteins involved in respiration, these strains were
evaluated with respect to cell growth when transferred from Fe
deficiency to medium containing a nonfermentable carbon source
(glycerol), for which respiration is indispensable. Under these
conditions, cells lacking a functional Cth2 protein (cth2 or
CTH2-C190R) show a significant delay in growth compared to
cells expressing wild-typeCTH2 (Fig. 7D). However, cells express-
ing CTH2-AREmt show a more severe delay when transferred to
respiratory conditions (Fig. 7D). Taken together, these results
support the hypothesis that maintaining appropriate concentra-
tions of Cth2 is important during Fe scarcity and in response to Fe
supplementation. Moreover, the rapid shutdown of Cth2 expres-
sion, mediated at least in part byCTH2 autoregulation, is required
for resuming growth in response to changes in cellular Fe de-
mands and Fe bioavailability.
DISCUSSION
Eukaryotic cells regulate gene expression at transcriptional and
posttranscriptional levels to rapidly respond to environmental
changes. In S. cerevisiae, the Aft1 and Aft2 transcription factors
promote the transcriptional activation of genes encoding proteins
that participate in extracellular Fe acquisition, Fe mobilization
and recycling, and metabolic remodeling when Fe bioavailability
is low (15–17). Furthermore, during Fe deficiency, a decrease in
the levels of some Fe-dependent metabolites, including heme and
-isopropylmalate, leads to downregulation in the transcription
of genes that function in respiration and leucine synthesis, respec-
tively (33). In addition to this transcriptional regulation mediated
by Fe-responsive metabolites, the metabolic reprogramming ob-
served in response to low Fe is also posttranscriptionally con-
trolled by the mRNA-binding proteins Cth1 and Cth2 (19, 20).
Both the Cth1 and Cth2 proteins bind ARE-containing mRNAs
encoding proteins that contain Fe as a cofactor, participate in
Fe-dependent processes, or function in Fe storage. Through the
generation of chimeric mRNAs, ARE mutagenesis, and in vivo
protein-RNA interaction assays, we demonstrate here that Cth1
and Cth2 proteins specifically bind functional AREs within the
3=UTRs of CTH1 and CTH2 transcripts, promoting autologous
and heterologous mRNA degradation.
We previously demonstrated by chromatin immunoprecipita-
tion experiments and CTH1 promoter fusion analysis that Aft1
and Aft2 specifically activate the transcription of CTH1 mRNA
during Fe deficiency (20). However, steady-state CTH1 transcript
levels are not detectably increased in Fe-deficient cells incubated
in 100 M BPS for 8 to 9 h (19) (Fig. 2A, CTH2). The increase in
CTH1 or GCN4-(CTH1-3=UTR) mRNA levels in cells lacking a
functional Cth2 or Cth1 protein, respectively, suggests that the
lack or very weak elevation of CTH1 transcript in response to low
Fe is due to a combination of Aft1/2-mediated transcriptional
activation coupled to active CTH1 mRNA degradation by both
Cth1 and Cth2 proteins (Fig. 2 and data not shown). At the pro-
tein level, wild-type cells display a modest and transient increase in
Cth1 protein 2 h after imposition of Fe deficiency (20). Impor-
tantly, when CTH2 is absent, Cth1 protein levels robustly accu-
mulate over a time course of several hours of Fe limitation. These
results suggest that during the progression of Fe deficiency, Cth2
protein levels increase and accelerate CTH1 mRNA decay, thus
restricting Cth1 expression to the initial stages of Fe limitation and
leaving Cth2 as the dominant regulator during severe or pro-
longed Fe deficiency. Given that the Cth1 and Cth2 proteins have
only slightly overlapping target mRNAs (20), we propose that this
cross-regulation could establish the priority by which Fe-depen-
dent processes are downregulated during the progression in sever-
ity of Fe deficiency. At the beginning of Fe deficiency, respiration
and other processes might be primarily targeted for downregula-
tion by Cth1 (20). When Fe deficiency persists, Cth2 would lead
the downregulation of other Fe-dependent processes and vacuolar
Fe storage, in addition to respiration. Previous studies (31) and
our results also indicate that Cth1 protein downregulates CTH2
mRNA, although this is a relatively modest effect, perhaps due to
the low CTH1 expression levels compared to CTH2 under low-Fe
conditions.
Although bothCTH1 andCTH2 contribute to yeast adaptation
to Fe deficiency, cells lacking a functional Cth2 protein exhibit a
pronounced growth defect under Fe-limited conditions, whereas
no growth defect has been observed for cth1 cells (19). A role for
CTH1 in cell growth under low Fe has been observed only in the
cth1 cth2 double mutant (19). While the primary reason for
Cth2 predominance in the response to Fe deficiency may be high
expression levels, it could also be due to the larger number of
transcripts whose degradation under Fe deficiency is Cth2 depen-
dent (20). Previous results demonstrated that Cth2 overexpres-
sion inhibits growth, suggesting that this may be due to excessive
degradation of transcripts encoding proteins important for cell
growth (21, 31). Cth2 toxicity can be rescued by removing its
ability to bind and degrade mRNAs, since Cth2 TZF mutagenesis
or deletion of genes implicated in the mechanism of Cth2-medi-
ated mRNA turnover, such as the RNA helicase gene DHH1, res-
cues growth (21, 31). Here, we show how CTH2 transcripts lack-
ing a functional ARE program a robust increase in Cth2 protein
levels under low-Fe conditions compared to wild-type cells. This
elevated expression of Cth2 is harmful for the cell, as shown by the
growth defect displayed by the CTH2-AREmt mutants under
low-Fe conditions and the delay in growth recovery during the
adaptation to Fe supplementation. Several reasons, including the
excessive degradation of specific mRNAs and the titration of pro-
teins required for global mRNA turnover, could be responsible for
these defects. Further studies are necessary to decipher the mech-
anism underlying the defects associated with cells that overexpress
a functional Cth2 protein.
We have shown that Cth2 autoregulation limits CTH2 expres-
sion levels, which prevents excessive accumulation that could be
deleterious to cell growth, but why do cells simultaneously tran-
scribe and degrade CTH2 mRNA instead of simply decreasing its
transcription rate? Previous studies have shown that simultaneous
activation of both transcription and degradation permits more
rapid and sensitive changes in gene expression that are advanta-
geous in response to environmental stresses (34, 35). In mammals,
an analogous mRNA-binding protein, TTP, specifically binds in
vivo to AREs within the 3=UTRs of many transcripts, stimulating
their delivery and degradation in processing bodies (18, 36). Re-
cent studies indicate that TTP-mediated regulation of gene ex-
pression plays an important role in tumorigenesis (37). It has been
proposed that TTP binds its own transcript and promotes mRNA
degradation in an autoregulatory pathway that limits TTP synthe-
sis (38, 39). This feedback-regulatory loop could facilitate a rapid
return to a resting, nonactivated state upon removal of the activa-
tion signal (38). To explore the physiological relevance of this
regulatory loop in yeast, we investigated the contribution of Cth2
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autoregulation to the adaptation of Fe-deficient cells to a rapid
increase in Fe availability. We first observed that when cells are
transferred from Fe-deficient to Fe-sufficient conditions, Cth2
protein rapidly disappears, perhaps to facilitate the reemergence
of respiration and other Fe-dependent processes repressed by
Cth2 in order to enhance energy production and cell growth and
to allow storage of Fe in excess of cellular needs. Importantly, in
the absence of ARE-mediated downregulation of CTH2 mRNA,
Cth2 protein levels are further sustained after Fe addition. As a
consequence, we observed that CTH2-AREmt cells exhibit pro-
longed repression of Fe-dependent processes during the shift to Fe
sufficiency, as shown by the decreased mRNA, protein, and enzy-
matic activities of Cth2 targets, which leads to a significant delay in
cell growth recovery compared to wild-type cells.
Taken together, the results described here demonstrate that the
expression of the yeast RNA-binding proteins Cth1 and Cth2 dur-
ing Fe deficiency is tightly controlled in a coordinated manner
through simultaneous transcriptional and posttranscriptional
mechanisms, as we depict in a summarized model (Fig. 8). Deg-
radation of CTH1 mRNA triggered by Cth2 allows the replace-
ment of Cth1 by Cth2 protein during the progress of Fe deficiency,
whereas Cth2 autoregulation enhances the response of Fe-defi-
cient cells to a rapid increase in Fe availability by decreasing Cth2
levels and permitting the activation of Fe-dependent processes
crucial for optimal cell growth. As Fe deficiency is a common
human nutritional deficiency that is treated with Fe supplements,
these studies underscore the potential complex metabolic rear-
rangements that must occur in response to fluctuations in the
availability of this essential metal.
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